This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Jonathan Green
Jon started his career in academia as a member of scientific staff in the Biochemistry Department, Imperial College and then as a Senior Scientific Officer with the Medical Research Council Toxicology Unit. Jon joined Cambridge Antibody Technology (CaT), in 1992 as a Senior Scientist, initially working on several drug discovery projects. Jon then helped establish the CaT process development group before moving across to operational management. Jon held the post of VP Site General Manager, at what was MedImmune, a wholly-owned subsidiary of AstraZeneca, formed through the merger of CaT and MedImmune where Jon was responsible for leading the site operations of the Cambridge R&D facilities. Jon has held the position of Chair of the Board of One Nucleus and Chief Operating Officer of Iontas, a well-known antibody engineering CRO.
Jon is currently a Scientific and Laboratory Consultant at Coel, a Consultant at Blackpowder Consulting, Chief Operating Officer at ImmuONE, and holds several other directorships and NED appointments.
Jon has a MPhil in molecular biology/cellular pathology, is a Chartered Biologist, a Fellow of the Royal Society of Biology, the Royal Society of Arts and Manufacturing and Fellow of the Institute of Directors.